Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/A1ZN34 stock hub

BVMF/A1ZN34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/A1ZN34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4T

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/A1ZN34

In the news

Latest news · BVMF/A1ZN34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.2

P25 11.3P50 14.6P75 19.6

Trailing P/E25.5

P25 15.2P50 21.5P75 27.3

ROE23.5

P25 5.3P50 12.3P75 22.5

ROIC16.4

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/A1ZN34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	BR
Employees	96,100
Employees Change	4,400%
Employees Change Percent	4.89
Enterprise value	BRL 1.5T
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 1.4T
Price	BRL 149
Price currency	BRL
Rev Per Employee	3,280,891.18x
Sector	Healthcare
Sic	2834
Symbol	bvmf/A1ZN34
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.92%
EV Earnings	27.95x
EV/EBIT	20.1x
EV/EBITDA	14.7x
EV/FCF	25.71x
EV/Sales	4.96x
FCF yield	4.27%
Forward P/E	17.16x
P/B ratio	5.59x
P/E ratio	25.48x
P/S ratio	4.38x
PE Ratio10 Y	84.81x
PE Ratio3 Y	31.68x
PE Ratio5 Y	131.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.69%
EBITDA Margin	33.08%
FCF margin	18.68%
Gross margin	81.51%
Gross Profit	BRL 257B
Gross Profit Growth	8.69%
Gross Profit Growth Q	11.17%
Gross Profit Growth3 Y	10.18%
Gross Profit Growth5 Y	17.61%
Net Income	BRL 54.2B
Net Income Growth	33.67%
Net Income Growth Q	5.62%
Net Income Growth3 Y	30.22%
Net Income Growth5 Y	21.17%
Pretax Margin	21.37%
Profit Margin	17.19%
Profit Per Employee	BRL 563,960
ROA	8.47
Roa5y	5.95
ROCE	18.32
ROE	23.48
Roe5y	13.03
ROIC	16.4
Roic5y	13.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.73%
Cagr3y	8.16%
Div CAGR3	11.04%
EPS Growth	33.61
EPS Growth Q	5.35
EPS Growth3 Y	30.03
EPS Growth5 Y	16.98
FCF Growth	1.26%
FCF Growth Q	-14.37%
FCF Growth3 Y	9.55%
FCF Growth5 Y	15.06%
OCF Growth	8.66%
OCF Growth Q	-9.53%
OCF Growth10 Y	11.98%
OCF Growth3 Y	13.57%
OCF Growth5 Y	16.62%
Revenue Growth	9.93x
Revenue Growth Q	12.51x
Revenue Growth3 Y	11.3x
Revenue Growth5 Y	16.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.55
Assets	BRL 594.8B
Cash	BRL 40B
Current Assets	BRL 145.5B
Current Liabilities	BRL 160.1B
Debt	BRL 177.5B
Debt EBITDA	BRL 1.67
Debt Equity	BRL 0.72
Debt FCF	BRL 3.01
Equity	BRL 247.2B
Interest Coverage	10.59
Liabilities	BRL 347.6B
Long Term Assets	BRL 449.3B
Long Term Liabilities	BRL 187.5B
Net Cash	BRL -137.5B
Net Cash By Market Cap	BRL -9.95
Net Debt EBITDA	BRL 1.32
Net Debt Equity	BRL 0.56
Net Debt FCF	BRL 2.33
Tangible Book Value	BRL -56.2B
Tangible Book Value Per Share	BRL -36.27
WACC	5.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	1.8
Net Working Capital	BRL -13.4B
Quick ratio	0.7
Working Capital	BRL -15.4B
Working Capital Turnover	BRL -106

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%
Dividend Growth	-2.07%
Dividend Growth Years	4%
Dividend per share	BRL 2.72
Dividend Years	5
Dividend Yield	1.83%
Ex Div Date	2026-02-19
Last Dividend	BRL 1.84
Payout Frequency	Semi-Annual
Payout Ratio	46.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.72%
200-day SMA	156.5
3Y total return	26.54%
50-day SMA	166
50-day SMA vs 200-day SMA	50over200
All Time High	190.4
All Time High Change	-21.88%
All Time High Date	2026-02-18
All Time Low	93.74
All Time Low Change	58.68%
All Time Low Date	2022-10-20
ATR	3.11
Beta	0.28
Ch YTD	-11.8
High	149.5
High52	190.4
High52 Date	2026-02-18
High52ch	-21.54%
Low	148.9
Low52	123.8
Low52 Date	2025-05-14
Low52ch	20.67%
Ma50ch	-10.41%
Price vs 200-day SMA	-4.92%
RSI	31.32
RSI Monthly	52.45
RSI Weekly	40.54
Sharpe ratio	0.38x
Sortino ratio	0.82
Total Return	1.91%
Tr YTD	-10.91
Tr1m	-14.21%
Tr1w	-2.12%
Tr3m	-8.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 77.9B
Operating Income Growth	10.65
Operating Income Growth Q	17.2
Operating Income Growth3 Y	14.17
Operating Income Growth5 Y	29.99
Operating margin	24.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,543,451,508%
Net Borrowing	5,857,726,400
Shares Insiders	0.04%
Shares Institutions	65.67%
Shares Qo Q	-0.13%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 57B
Average Volume	236x
Bv Per Share	159.4
CAPEX	BRL -15.3B
Ch1m	-14.21
Ch1w	-2.12
Ch1y	10.86
Ch3m	-9.87
Ch3y	19.5
Ch6m	-1.16
Change	0.43%
Change From Open	0.33
Close	148.8
Days Gap	0.1
Depreciation Amortization	24,914,994,000
Dollar Volume	1,792.7
Earnings Date	2026-04-29
EBIT	BRL 77.9B
EBITDA	BRL 104.3B
EPS	BRL 34.64
F Score	7
FCF	BRL 58.9B
FCF EV Yield	3.89x
Financing CF	-23,840,433,250
Fiscal Year End	December
Founded	1,992
Goodwill	104,151,554,800
Graham Number	59.12838
Graham Upside	-60.25
Income Tax	BRL 13.2B
Investing CF	-38,327,278,575
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2026-02-02
Last Split Type	Reverse
Lynch Fair Value	BRL 124
Lynch Upside	-16.92
Ma150	162.1
Ma150ch	-8.26%
Ma20	160.8
Ma20ch	-7.48%
Net CF	12,034,984,575
Next Earnings Date	2026-07-27
Open	148.9
P FCF Ratio	23.44
P OCF Ratio	18.62
Payment Date	2026-03-27
Position In Range	76.56
Ppne	73,423,062,200
Price Date	2026-05-08
Price EBITDA	BRL 13.24
Relative Volume	0.05x
Revenue	315,293,642,275x
SBC By Revenue	0.61x
Share Based Comp	1,909,321,350
Tax By Revenue	4.17x
Tax Rate	19.52%
Tr6m	-0.17%
Volume	12
Z Score	3.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/A1ZN34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$2.72 annual per share

Payout ratio

+46.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

4 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-02-19

Performance

BVMF/A1ZN34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/A1ZN34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+65.7%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

BVMF/A1ZN34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.3

Neutral momentum band

Price vs 200-day MA

-4.9%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/A1ZN34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/A1ZN34 stock rating?

bvmf/A1ZN34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/A1ZN34 analysis?

The full report lives at /stocks/bvmf/A1ZN34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/A1ZN34?

The latest report frames bvmf/A1ZN34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/A1ZN34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.